Company Filing History:

8 out of 637

Bristol-myers Company

patents

5 out of 3,681

Bristol-myers Squibb Compnay

patents

Years Active: 1989-1998

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5837828 - Pradimicin derivatives (1998-11-17),

2. 5410029 - Pradimicin derivatives (1995-04-25),

3. 5093248 - BU-3862T antitumor antibiotic (1992-03-03),

4. 5089522 - Antitumor antibiotic BU-3285T (1992-02-18),

5. 5066645 - Epipodophyllotoxin altroside derivatives (1991-11-19),

6. 5036055 - Acylated derivatives of etoposide (1991-07-30),

7. 5036008 - Antitumor antibiotic BU-3285T (1991-07-30),

8. 5034380 - Alkoxymethylidene epipodophyllotoxin glucosides (1991-07-23),

9. 4952709 - Antitumor antibiotic BU-3285T compounds (1990-08-28),

10. 4912204 - Fluoro-substituted epipodophyllotoxin glucosides (1990-03-27),

11. 4912133 - BU-3862T antitumor antibiotic (1990-03-27),

12. 4883758 - Biologically pure culture of the microorganism Streptomycas (1989-11-28),

13. 4833079 - Process for producing 3,7-dihydroxytropolone and antitumor use thereof (1989-05-23),

Title: Hideo Kamei: Innovator in Antifungal Agents

Introduction: Hideo Kamei is a prominent inventor located in Tokyo, Japan, with a notable portfolio of 13 patents. His work primarily focuses on the development of novel antifungal agents, showcasing his dedication to advancing pharmaceutical innovations. Kamei's contributions to science have made significant impacts in the field, particularly through his research and findings.

Latest Patents: Among his latest innovations, Kamei has developed a patent concerning pradimicin derivatives, which includes neutral sugar derivatives of pradimicins. These compounds demonstrate potential as antifungal agents, exploring methods for their preparation and intermediates for synthesis. This advancement reflects Kamei's commitment to enhancing treatment options for fungal infections.

Career Highlights: Throughout his career, Hideo Kamei has worked with esteemed companies such as Bristol-Myers Company and Bristol-Myers Squibb Company. His tenure at these organizations has allowed him to collaborate on critical pharmaceutical projects, ultimately leading to his numerous patent applications and contributions to the field of medicinal chemistry.

Collaborations: Kamei's work has also involved collaboration with notable colleagues in the industry, including Koji Tomita and Masataka Konishi. Together, they have contributed to the development of innovative solutions and advancements in antifungal therapies.

Conclusion: Hideo Kamei stands out as a significant figure in the realm of innovation, with a particular focus on antifungal agents. His patents and collaborations highlight his dedication to advancing medical science, paving the way for future developments in the pharmaceutical industry. Kamei's expertise and contributions continue to influence the landscape of medicinal research and innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.